Remove Manufacturing Remove Patients Remove Pharmaceutical research
article thumbnail

Why is microbiological testing in medical device manufacturing important?

European Pharmaceutical Review

A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures. Sharma et al.

article thumbnail

CPHI to return to Milan in 2024

European Pharmaceutical Review

The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Navigating Pharma Sales Challenges: Tips to Boost Your Sales Performance (Use of AI and Social Media for Effective brand promotion)

Pharmaceutical Representative Training

Social medias position in pharmaceutical research is further cemented by peoples growing usage of it. Healthcare professionals are also catching up to the patient group, which has long been engaged on social media. It can be applied to comprehend patient difficulties and spot chances for clinical intervention.

Media 52
article thumbnail

Machine learning can predict outcomes for inkjet printed pharmaceuticals

European Pharmaceutical Review

percent, a paper published in International Journal of Pharmaceutics: X has shown. This is especially true for additive manufacturing and the production of unique dosage forms and personalised medicines. Using inkjet printing, optimised machine learning (ML) models predicted the printability of drug formulations with an accuracy of 97.22

article thumbnail

Post-approval R&D key in advancing oncology treatments

European Pharmaceutical Review

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) has highlighted the importance of post-approval R&D in advancing oncology treatment options and delivering unprecedented progress over the past ten years. This therefore broadens the population of patients who may benefit.

article thumbnail

Optimising drug release of personalised 3D printed tablets

European Pharmaceutical Review

Key study findings Study results demonstrated that precise control of tablet surface geometry “effectively tailored drug release profiles, enhancing patient compliance and treatment efficacy”. their approach in the study addresses “diverse pharmaceutical manufacturing demands”. This paper is published in Pharmaceutical Research.

article thumbnail

Pharma’s ESG goals need to underscore push for health equity

Pharmaceutical Technology

Dall talked about GlobalData’s partnership with the trade organisation Pharmaceutical Research and Manufacturers of America (PhRMA), which has allowed for a focused effort to analyse and tackle health equity issues within the United States (US). . trillion in savings over the next decade.